Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The United States Food and Drug Administration (FDA) announced that over-the-counter (OTC) asthma inhaler, Primatene Mist, containing chlorofluorocarbons (CFCs) will be taken off the US market from 31 December.
Subscribe to our email newsletter
The CFCs present in the product deplete the earth’s ozone layer.
The decision follows the Montreal Protocol treaty to stop the use of substances that damage the environment.
In an attempt to help asthma patients through the transition, Teva Respiratory is making asthma product samples available to the patients through healthcare practitioners.
The products which will me made available include ProAir HFA (albuterol sulfate) Inhalation Aerosol (quick-relief albuterol inhaler) and QVAR (beclomethasone dipropionate HFA) Inhalation Aerosol (asthma control inhaler).